J. Sergi

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.

Ronald M. Bukowski, William Sharfman, S. Murthy et al. · PubMed · 1991 · 102 citations

Medicine, Immunology, Oncology +17

Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group Study

Ronald M. Bukowski, Phyllis J. Goodman, E. David Crawford et al. · JNCI Journal of the National Cancer Institute · 1990 · 98 citations

Medicine, Oncology, Pharmacology +15

Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.

G. Thomas Budd, B Osgood, Barbara P. Barna et al. · PubMed · 1989 · 57 citations

Medicine, Oncology, Pharmacology +13

Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy.

G. Thomas Budd, S. Murthy, James H. Finke et al. · Journal of Clinical Oncology · 1992 · 43 citations

Pharmacy, Oncology, Pharmacology +17

Phase I study of WR-2721 and carboplatin

G. Thomas Budd, Ram Ganapathi, L. Bauer et al. · European Journal of Cancer · 1993 · 23 citations

Life Sciences, Molecular Biology, Cell Cycle +1